کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3075509 | 1580965 | 2013 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects? Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?](/preview/png/3075509.png)
The objective of our study was to evaluate whether cognitively normal (CN) elderly participants showing elevated cortical beta-amyloid (Aβ) deposition have a consistent neuroanatomical signature of brain atrophy that may characterize preclinical Alzheimer's disease (AD). 115 CN participants who were Aβ-positive (CN +) by amyloid PET imaging; 115 CN participants who were Aβ-negative (CN −); and 88 Aβ-positive mild cognitive impairment or AD participants (MCI/AD +) were identified. Cortical thickness (FreeSurfer) and gray matter volume (SPM5) were measured for 28 regions-of-interest (ROIs) across the brain and compared across groups. ROIs that best discriminated CN − from CN + differed for FreeSurfer cortical thickness and SPM5 gray matter volume. Group-wise discrimination was poor with a high degree of uncertainty in terms of the rank ordering of ROIs. In contrast, both techniques showed strong and consistent findings comparing MCI/AD + to both CN − and CN + groups, with entorhinal cortex, middle and inferior temporal lobe, inferior parietal lobe, and hippocampus providing the best discrimination for both techniques. Concordance across techniques was higher for the CN − and CN + versus MCI/AD + comparisons, compared to the CN − versus CN + comparison. The weak and inconsistent nature of the findings across technique in this study cast doubt on the existence of a reliable neuroanatomical signature of preclinical AD in elderly PiB-positive CN participants.
► We measured atrophy in cognitively normal subjects with amyloid deposition (CN +).
► Findings in CN + subjects were weak and disconcordant across Freesurfer and SPM5.
► Concordance across techniques was higher when assessing Alzheimer disease subjects.
► Evidence for a neuroanatomical signature of preclinical AD in CN + subjects is weak.
Journal: NeuroImage: Clinical - Volume 2, 2013, Pages 249–257